3 completed, 1 active not recruiting. 4 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Active not recruiting 1 |
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
Follow Pujol, Aurora, M.D.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dimethyl Fumarate in Adrenomyeloneuropathy Placebo, Dimethyl fumarate - Adrenomyeloneuropathy Without Cerebral Involvement | Phase 2 / Phase 3 | Active not recruiting | Pujol, Aurora, M.D. | 40 | 2024-04-23 | 2026-06-17 |
| Plasma Exchange With Albumin in AMN Patients Albumin solution - Adrenomyeloneuropathy, Adrenoleukodystrophy | Phase 2 / Phase 3 | Completed | Pujol, Aurora, M.D. | 5 | 2020-03-09 | 2022-09-22 |
| Effect of Pioglitazone Administered to Patients With Adrenomyeloneuropathy Pioglitazone - Adrenomyeloneuropathy, X-linked Adrenoleukodystrophy | Phase 2 | Completed | Pujol, Aurora, M.D. | 18 | 2016-01-01 | 2019-09-10 |
| A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of Antioxidants N-acetylcysteine, lipoic acid, vitamin E - Adrenomyeloneuropathy | Phase 2 | Completed | Pujol, Aurora, M.D. | 13 | 2011-09-01 | 2019-03-11 |
Acetylcysteine (1) · Dimethyl Fumarate (1) · Pioglitazone (1) · Plasma Exchange (1) · Thioctic Acid (1) · Vitamin E (1)
Spain (4)
Carlos Casasnovas, MD, PhD (1)